Context.-The prostate sampling methods for radical cystoprostatectomy (RCP) specimens may affect pathologic results. Objective.-To investigate the impact on the tumor stage and clinicopathologic features according to the prostate sampling method for RCP specimens. Design.-From 2016 to 2017, the prostate in RCP was minimally and conventionally embedded (group 1, n 98). From 2017 to 2018, it was completely embedded (group 2, n 102). Results.-Group 2 was more likely to have prostatic ducts or acini involvement by urothelial carcinoma in situ component (27% versus 10%, P .002) and prostate involvement (30% versus 13%, P .003) than group 1. Although there were cases with prostatic stromal invasion in group 2 (14% versus 7%, P .13), this was not statistically significant. In all, 6 cases were upstaged by subepithelial prostatic stromal invasion through intraurethral extension according to the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. Tumor location and the presence of concurrent carcinoma in situ were strongly associated with prostate involvement of urothelial carcinoma. Prostatic adenocarcinoma (PA) was incidentally identified in 47 cases (23.5%). Incidental PA and clinically significant PA were more often identified in group 2 than group 1 (38% versus 8%, P , .01 and 15% versus 6%, P .048, respectively). Conclusions.-A complete prostate examination in RCP specimens can be suggested, since the final pathologic stage can be changed through a thorough prostate examination especially in accord with the AJCC staging manual 8th edition. In addition, the complete prostate analysis could detect more incidental and clinically significant PA.
Bibliographical noteFunding Information:
This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI21C0977).
© 2023 College of American Pathologists. All rights reserved.